Fabrice André

Title: Fabrice André: Innovator in Breast Cancer Prognosis

Introduction

Fabrice André is a notable inventor based in Paris, France. He has made significant contributions to the field of medical technology, particularly in breast cancer prognosis. His innovative work focuses on utilizing machine learning to enhance predictive capabilities in oncology.

Latest Patents

Fabrice André holds a patent for "Systems and methods for determining breast cancer prognosis and associated features." This patent describes a computer-implemented method and a machine learning model designed to predict the likelihood of relapse in breast cancer patients following treatment. It also includes the ability to predict tumors within whole slide images and assess the status of biomarkers in breast cancer tissue.

Career Highlights

Throughout his career, Fabrice André has worked with prominent companies in the medical technology sector, including Owkin France SAS and Owkin, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in cancer treatment and prognosis.

Collaborations

Fabrice has collaborated with notable professionals in his field, including Benoit Schmauch and Charlie Saillard. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Fabrice André is a pioneering inventor whose work in breast cancer prognosis exemplifies the intersection of technology and healthcare. His contributions are vital in improving patient outcomes and advancing medical research.